Indian Pharma - Live Stock Quotes, Stock Price Update and Analysis from Equitymaster.com
X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian Pharma Stocks 

Here are the latest stock price details of India's top Indian Pharma stocks. For more detailed updates, read our Indian Pharma sector report and check the latest Indian Pharma sector results.

» Result Scoreboard | Best Performing Stocks | Refresh
SCRIP BSE PRICE (Rs) NSE PRICE (Rs) CHART MORE INFO
AARTI DRUGS 626.15 0.30% 624.40 -0.51%
 More Info 
AJANTA PHARMA 1,024.25 -0.76% 1,027.00 -0.54%
 More Info 
ALEMBIC PHARMA 534.40 0.14% 535.55 0.33%
 More Info 
BIOCON 615.30 -1.26% 615.20 -1.17%
 More Info 
CADILA HEALTHCARE 336.85 -0.37% 336.50 -0.41%
 More Info 
CIPLA 562.00 0.48% 561.55 0.39%
 More Info 
DIVIS LABORATORIES 1,725.40 0.38% 1,724.35 0.57%
 More Info 
GLENMARK PHARMA 639.60 -0.64% 639.15 -0.58%
 More Info 
INDOCO REMEDIES 198.80 -2.29% 199.05 -2.95%
 More Info 
IPCA LABS 968.95 2.98% 964.05 1.88%
 More Info 
J.B.CHEMICALS 347.75 -1.71% 347.30 -2.09%
 More Info 
LUPIN 834.10 0.25% 835.80 0.34%
 More Info 
NATCO PHARMA 541.75 -3.16% 539.05 -3.96%
 More Info 
NIFTY 50 Not Listed 11,752.80 -0.29%
 More Info 
ORCHID PHARMA LTD 5.69 3.45% 18.90 -2.83%
 More Info 
PANACEA BIOTECH 201.70 -2.54% 201.95 -2.27%
 More Info 
PIRAMAL ENTERPRISES 2,653.95 -0.79% 2,649.85 -0.86%
 More Info 
S&P BSE SENSEX 39,140.28 -0.34% Not Listed
 More Info 
STRIDES PHARMA SCIENCE 488.25 -1.46% 487.65 -1.51%
 More Info 
SUN PHARMA 462.10 -0.04% 463.20 0.14%
 More Info 
TORRENT PHARMA 1,829.15 -0.43% 1,836.60 -0.14%
 More Info 
WOCKHARDT 439.10 -3.19% 439.15 -3.22%
 More Info 

BSE prices: April 18, 2019  (Close)    NSE prices: April 18, 2019  (Close)

Indian Pharma Stocks Update

The NIFTY PHARMA Index was at 9,406.0 (down 0.1%). The index is down 8.7% over the last 30 days. And over the last 1 year, it has gained 0.1%.

Within the Indian Pharma sector, the top gainers were ORCHID PHARMA LTD (up 3.5%) and IPCA LABS (up 3.0%). On the other hand, WOCKHARDT (down 3.2%) and NATCO PHARMA (down 3.2%) were among the top losers.

Meanwhile, the benchmark NIFTY 50 was at 11,752.8 (down 0.3%).




Today's Market

Sensex at New Highs, Jet Airways Suspends Operations - Your Inside Scoop of the Markets(Podcast)

Jet Airways, once India's largest private airline halted its operations indefinitely yesterday. The carrier flew its last scheduled flight from Amritsar to Mumbai yesterday.

Related Views on News

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

PANACEA BIOTECH Announces Quarterly Results (3QFY19); Net Profit Down 137.1% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, PANACEA BIOTECH has posted a net profit of Rs 230 m (down 137.1% YoY). Sales on the other hand came in at Rs 1 bn (down 25.2% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

GLENMARK PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 11.1% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, GLENMARK PHARMA has posted a net profit of Rs 1 bn (up 11.1% YoY). Sales on the other hand came in at Rs 26 bn (up 15.9% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE HEALTHCARE


Apr 18, 2019 (Close)

COMPARE COMPANY

MARKET STATS